Enfusion Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Enfusion Stock Summary

Enfusion competes with ON24, Paycor HCM, E2open Parent, Braze, and Freshworks. Enfusion, Inc. provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. Enfusion Inc. was incorporated in 2021 and is headquartered in Chicago, Illinois. Enfusion Inc operates under SoftwareApplication classification in the United States and is traded on New York Stock Exchange. It employs 892 people.

Enfusion Key Financial Ratios

Enfusion Key Balance Sheet Accounts

Enfusion Key Income Statement Accounts

Enfusion Key Cash Accounts

Enfusion Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Enfusion's current stock value. Our valuation model uses many indicators to compare Enfusion value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Enfusion competition to find correlations between indicators driving Enfusion's intrinsic value. More Info.Enfusion is rated # 3 in return on equity category among its peers. It also is rated # 3 in return on asset category among its peers reporting about  0.69  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Enfusion is roughly  1.45 . At this time, Enfusion's Return On Equity is very stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Enfusion's earnings, one of the primary drivers of an investment's value.

Enfusion Systematic Risk

Today, most investors in Enfusion Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Enfusion's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Enfusion growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Enfusion help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Enfusion. We use our internally-developed statistical techniques to arrive at the intrinsic value of Enfusion based on widely used predictive technical indicators. In general, we focus on analyzing Enfusion Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Enfusion's daily price indicators and compare them against related drivers.

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Enfusion. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census. To learn how to invest in Enfusion Stock, please use our How to Invest in Enfusion guide.You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.

Is Application Software space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Enfusion. If investors know Enfusion will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Enfusion listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Enfusion is measured differently than its book value, which is the value of Enfusion that is recorded on the company's balance sheet. Investors also form their own opinion of Enfusion's value that differs from its market value or its book value, called intrinsic value, which is Enfusion's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Enfusion's market value can be influenced by many factors that don't directly affect Enfusion's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Enfusion's value and its price as these two are different measures arrived at by different means. Investors typically determine if Enfusion is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Enfusion's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.